Recently, Gecell has achieved a significant development milestone - in June 2025, it officially became the first internship training unit in Mainland China for the Capstone Program of the National University of Singapore (NUS) Master's Program in Precision Health and Medicine. At the same time, Gecell successfully signed a cooperation agreement with the Fudan Lingang Industrialization Innovation Platform. A series of initiatives demonstrate Gecell 's professional strength and industry influence in the field of immune cell therapy, and also inject new vitality into global students and industrial development.

As a world - renowned top university, the Capstone Program of NUS's Master's Program in Precision Health and Medicine is famous for its high standards and strict requirements, aiming to provide students with a valuable opportunity to transform theoretical knowledge into practical ability. Gecell,with its profound accumulation and cutting - edge exploration in the field of immune cell therapy such as CAR - NK, stood out from many candidate units and became the first internship training unit of the program in Mainland China. This is not only a high recognition of Gecell 's professional level and industry status, but also builds an important bridge for academic exchanges and talent training in the field of precision health and medicine between the two countries.

While becoming the internship training unit of the relevant program of NUS, Gecell signed a cooperation agreement with the Fudan Lingang Industrialization Innovation Platform. The two parties will work together to provide high - quality CAR - NK industry training courses for students from all over the world. The Fudan Lingang Industrialization Innovation Platform has rich experience and advantageous resources in the integration of industry, education and research, while Gecell has solid strength in CAR - NK technology research and development, clinical transformation and other aspects. This cooperation will integrate the advantages of both parties to create a training system integrating theoretical teaching, practical operation and industrial cognition, helping students deeply understand the development status, core technologies and future trends of the CAR - NK industry, and improving their professional quality and practical ability.

By becoming an internship training unit and carrying out industrial training courses, Gecell will create more high - quality employment opportunities for global students. During the training and internship, students can get close contact with cutting - edge technologies and actual projects in the industry, accumulate valuable work experience, and lay a solid foundation for their future employment in the field of immune cell therapy. At the same time, these initiatives will also effectively promote the talent training and reserve in the immune cell therapy industry, promote the innovative development of the industry, and further prosper the cultural and economic atmosphere of the immune cell therapy industry.

In the future, Gecell will take this opportunity to continuously deepen cooperation with institutions such as the National University of Singapore and the Fudan Lingang Industrialization Innovation Platform, continuously improve its scientific research strength and teaching level in the field of immune cell therapy, provide better training and internship resources for global students, and make greater contributions to the vigorous development of the immune cell therapy industry.